Drug Trial Radar · NCT00168636
Different Doses of Vitamin A Supplementation and Male and Female Morbidity and Mortality
Last checked: Nov 20, 2026Latest source record: Nov 15, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
11,000
Actual
Start
Nov 2004
Primary completion
Nov 2013
Sponsor
- Lead sponsor
- Bandim Health ProjectAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Sep 15, 2005
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Prevention
- Who can join
- All sexes, from 6 months, up to 5 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
We previously compared the effect on mortality of the half dose and the full dose currently recommended by WHO. Unexpectedly, the low dose was clearly better for girls, but not for boys. The girls' response might have depended on the last vaccine received before the OPV and VAS campaign. We believe that these findings call for confirmation. In connection with a new campaign, we will examine whether half the dose or the full dose has a more beneficial effect on mortality and morbidity in girls, and furthermore address the potential effect modification by the last vaccine received before the supplementation.
Conditions
- Mortality
- Morbidity
Interventions
Vitamin ADrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mortality
- Morbidity
- All outcomes are investigated for interactions between vitamin A, sex, and last vaccine received
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Bandim Health Project, Apartado 861
Bissau, Guinea-Bissau
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.